Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma

ŞÜKÜR Y. E., TAŞKIN S., VARLI B., Ates C., GÜNGÖR M., Ortac F.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.23, no.1, pp.114-120, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1007/s10147-017-1181-3
  • Journal Name: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.114-120
  • Keywords: Lymphadenectomy, Lymph node metastasis, Residual tumor, Survival, Uterine carcinosarcoma, GYNECOLOGIC-ONCOLOGY-GROUP, STAGE-I, CYTOREDUCTIVE SURGERY, SARCOMA-GROUP, UTERUS, THERAPY, CANCER, LYMPHADENECTOMY, CARBOPLATIN, PACLITAXEL
  • Ankara University Affiliated: Yes

Abstract

Uterine carcinosarcoma (UCS) is a relatively rare and very aggressive tumor. The predictors of survival for patients with UCS have not been determined clearly yet. The aim of the present study was to investigate the possible predictors of disease-free survival (DFS) and overall survival (OS) for patients with UCS.